Affiliation: Ludwig-Maximilians University, Institute for Cardiovascular Prevention (IPEK)

Dr. Ismail Cimen earned a BS in Biology from Hacettepe University in 2008 and completed a PhD in the Department of Biology at the Middle East Technical University in 2012. During subsequent postdoctoral training at the Department of Molecular Biology and Genetics, Bilkent University, he demonstrated that palmitoleate has preventive effects on complex metabolic and inflammatory diseases, such as atherosclerosis, by suppressing macrophage ER stress and inflammation. In 2016, Dr. Cimen relocated to the Institute for Cardiovascular Prevention (IPEK) at Ludwig-Maximilians University in Munich, where he showed that disrupting a miR-206-3p–CXCR4 interaction in vascular cells is atheroprotective in mice and promotes atheroprotective functions in human and mouse vascular cells in vitro. Currently, Dr. Ismail Cimen's research is centered on unraveling the intricate role of DNA methylation and demethylation mechanisms in immune cells, specifically within the context of inflammatory diseases.